Zantac (Ranitidine) Cancer Lawsuits

Zantac (Ranitidine) Cancer Lawsuits in Syracuse, New York

For decades, Zantac (ranitidine) was one of the most widely used heartburn medications in America, prescribed to millions for acid reflux and GERD. However, in 2019, testing revealed that Zantac was contaminated with NDMA—a probable human carcinogen—at levels far exceeding safe limits. In April 2020, the FDA requested that all ranitidine products be removed from the market. If you developed cancer after taking Zantac, the experienced Zantac lawsuit attorneys at Gillette & Izzo in Syracuse can help you pursue compensation.

Call 315-421-1000 today for a free consultation with a Zantac cancer lawyer who will fight for your rights.

The Zantac NDMA Contamination Crisis

Zantac (ranitidine) was approved by the FDA in 1983 and became one of the world’s best-selling drugs. At its peak, an estimated 15 million Americans were taking ranitidine products[Zantac context].

Discovery of NDMA Contamination

In September 2019, independent laboratory testing detected N-Nitrosodimethylamine (NDMA)—a known carcinogen—in ranitidine products. NDMA is classified by the EPA and World Health Organization as a probable human carcinogen.

Further testing revealed alarming facts:

• NDMA levels in Zantac far exceeded the FDA’s acceptable daily intake limit of 96 nanograms

• Some tests showed NDMA levels over 3 million nanograms per tablet

• NDMA levels increased when Zantac was stored at room temperature or higher

• The contamination was inherent to the ranitidine molecule itself, not a manufacturing defect

• Both brand-name Zantac and generic ranitidine were affected

FDA Recalls All Ranitidine Products

On April 1, 2020, the FDA requested all manufacturers voluntarily withdraw ranitidine products from the U.S. market[Zantac context]. The FDA determined that NDMA levels in ranitidine increase over time and when stored at higher temperatures, posing unacceptable cancer risks to patients.

NDMA: A Potent Carcinogen

NDMA (N-Nitrosodimethylamine) is an organic chemical classified as a probable human carcinogen based on laboratory studies. According to the National Cancer Institute, NDMA exposure has been linked to multiple types of cancer.

How NDMA Causes Cancer

NDMA damages DNA, causing mutations that can lead to cancer development. The risk increases with:

• Duration of exposure (longer use = higher risk)

• Dosage (higher doses = higher risk)

• Individual susceptibility factors

The Centers for Disease Control and Prevention notes that NDMA is toxic to the liver and has been associated with liver cancer in animal studies.

Cancers Linked to Zantac (Ranitidine)

Zantac lawsuits allege that NDMA exposure from ranitidine caused various cancers, including:

Gastrointestinal Cancers

• Stomach cancer (gastric cancer)

• Esophageal cancer

• Colorectal cancer

• Intestinal cancer

• Liver cancer (hepatocellular carcinoma)

• Pancreatic cancer

Urological Cancers

• Bladder cancer

• Kidney cancer (renal cell carcinoma)

Blood Cancers

• Leukemia

• Non-Hodgkin’s lymphoma

• Multiple myeloma

Other Cancers

• Prostate cancer

• Breast cancer

• Ovarian cancer

• Uterine cancer

• Testicular cancer

• Thyroid cancer

Who Can File a Zantac Lawsuit?

You may have a Zantac cancer claim if you:

• Took Zantac (ranitidine) regularly for one year or more

• Were diagnosed with cancer after taking Zantac

• Were diagnosed with cancer within 10-20 years after taking Zantac (cancer can take years to develop)

• Have medical records documenting your Zantac use

• Have a confirmed cancer diagnosis

Even if you took generic ranitidine (not brand-name Zantac), you may still have a claim. The contamination affected all ranitidine products.

What Compensation Can a Zantac Lawsuit Recover?

Zantac cancer is devastating, and patients deserve full compensation for all damages. Our Syracuse Zantac lawsuit attorneys pursue:

Medical Expenses

• Cancer diagnosis and staging (biopsies, imaging, lab tests)

• Surgical treatment (tumor removal, organ resection)

• Chemotherapy (drugs, administration, monitoring)

• Radiation therapy

• Immunotherapy and targeted therapy

• Hospitalization for treatment and complications

• Home healthcare and nursing care

• Palliative care and pain management

• Future medical costs for ongoing treatment and monitoring

Lost Wages and Income

• Time off work during cancer treatment

• Lost income during disability

• Loss of earning capacity if you can’t return to your previous job

• Permanent disability benefits

• Loss of business opportunities and career advancement

Pain and Suffering

• Physical pain from cancer and treatment side effects

• Nausea, fatigue, and weakness from chemotherapy

• Surgical pain and recovery

• Emotional distress from cancer diagnosis

• Fear and anxiety about prognosis and death

• Depression from life-altering illness

• Loss of enjoyment of life

• Loss of consortium (impact on marriage and family relationships)

Wrongful Death Damages

If Zantac caused your loved one’s cancer death, we pursue:

• Funeral and burial expenses

• Loss of financial support for surviving family members

• Loss of companionship, guidance, and consortium

• Estate claims for the deceased’s pain and suffering before death

• Punitive damages (if applicable)

Punitive Damages

Zantac lawsuits may seek punitive damages if evidence shows that manufacturers:

• Knew about NDMA contamination before 2019

• Failed to test products adequately for impurities

• Concealed safety data from regulators and the public

• Prioritized profits over patient safety

The Status of Zantac Litigation

Thousands of Zantac cancer lawsuits have been filed nationwide. Many cases were consolidated in federal Multidistrict Litigation (MDL) in the Southern District of Florida.

Ongoing Litigation

While some early cases faced legal challenges, Zantac litigation is ongoing in both federal and state courts. New scientific evidence continues to emerge linking ranitidine exposure to cancer.

It’s not too late to file a claim. Statutes of limitations vary by state, but many cancer cases are still within filing deadlines.